Genotype-guided p2y12 inhibitor monotherapy within 7 days of percutaneous coronary intervention in high bleeding risk patients: the champ trial - a pilot study and safety assessment
Journal of the American College of Cardiology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要